Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Monomer Sciences was a biotechnology supplier primarily active in the 1990s and early 2000s, specializing in the production and distribution of high-purity reagents for nucleic acid research. The company was a notable provider of phosphoramidites, modified nucleoside monomers, and oligo(dT) cellulose used in the synthesis and purification of therapeutic and diagnostic oligonucleotides. Based in Alabama, it served as a key resource for academic and industrial laboratories developing antisense technologies and DNA microarrays. While the company was a significant player in the early oligonucleotide synthesis market, it appears to no longer be active as an independent entity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Monomer Sciences.